中国竞彩网,竞彩网足球,足彩开奖

 
2020年高层次人才招聘计划-20200217

中国医学科学院血液病医院(中国医学科学院血液学研究所)

2020年高层次人才招聘计划

  

  中国医学科学院血液病医院(中国医学科学院血液学研究所)创建于 1957 年,是我国最大的集医疗、科研、教学、产业于一体的国家级科研型血液病专业医疗机构,是隶属国家卫生健康委员会管理的三级甲等专科医院;是实验血液学国家重点实验室和国家血液系统疾病临床医学研究中心的依托单位,主要从事血液病及相关领域的基础研究和应用基础研究,血液病的临床诊断、治疗,大规模、多中心、高质量的临床诊疗规范研究,制定血液病诊疗技术规范,开展血液系统疾病诊疗新技术、新药物的评价研究和医学转化。血液病的诊断和治疗水平一直处于国内领先、在某些方面达到国际水平,并取得了一系列原创性成果。自2010年起连续十年获得医院专科声誉排行榜(血液学)第一名;自2014年起连续六年获得中国医院科技量值(STEM)排行榜(血液病学)第一名。血液病医院(血液学研究所)是国家创新人才培养示范基地,承担着国家干细胞工程技术研究中心、细胞产品国家工程技术研究中心、细胞产品产业化示范工程建设项目、国家“一带一路”联合实验室的建设任务。

  中国医学科学院北京协和医学院已全面实行准聘长聘系列教职聘任体系,血液病医院(血液学研究所)对顶级科学家和特别优秀的青年人才引进实行“个性化”的支持方案,提供充足的科研启动经费,并将根据需要提供进一步支持。

  根据血液病医院(血液学研究所)事业发展需求,现面向全球公开招聘高层次人才,需求岗位及有关要求如下:

一、招聘岗位

序号

需求岗位

需求专业

需求人数

招聘条件

1

中国竞彩网,竞彩网足球,足彩开奖:中心

主任

血液病理学或相关专业

1

1.博士学位,年龄在50岁(含)以下。

2.具有国内外知名高校和科研院所临床病理学、病理学、病理生理学及医学相关专业背景。

3.具有高水平的血液学病理诊断技术和经验;具有本学科高水平的科研、教学和管理能力;能指导本学科创新和发展。

4.具有较强沟通、协调和组织能力。

5.具有以下条件者优先考虑:

(1)在相关领域具有较深的学术造诣和成就,曾在高端学术期刊发表过具有影响力的学术论文。

(2)担任省级及以上医学会专业委员会委员及以上学术职务者。

(3)在发达国家取得血液病理医师资格者。

2

信息与资源中心

主任

生物信息或医疗数据

相关专业

1

1.博士学位,年龄在50岁(含)以下。

2.具有国内外知名高校、科研院所、企业从事生物统计学、流行病学、生物信息学或医疗大数据专业背景。

3.曾负责或主要参与多项课题、具有较强的医学数据分析能力和生物医学交叉领域相关项目设计与执行经验。

4.具备EMR数据库或区域数据库研究或医疗复杂大数据模型研究与应用等经验。

5.具有较强沟通、协调和组织能力。

3

实验血液学国家重点实验室及国家血液系统疾病临床医学研究中心

独立研究人员

流行病与分子流行病学

1

1.年龄在50岁(含)以下,在国内外知名高校和科研院所取得博士学位。

2.需在国外高校、科研院所担任相当于助理教授及以上职务或在国内著名高校、科研院所担任教授及相应职务。

3.在本专业方向具有较深的学术造诣和成就,曾在高端学术期刊发表多篇具有影响力的学术论文。

4.具有主持国内外各类重大科研项目的经历,把握科学研究前沿。

5.具有较强的团队合作精神,具有人才培养的经验和能力,能够带领团队开展学科建设与发展。

6.曾获得国内外高端人才称号或人才项目者优先。

4

生物信息与大数据

1

5

临床试验与生物统计

1

6

基因编辑与基因治疗

1

7

血液学或干细胞生物学

1

二、联系方式

  联系邮箱:chenboyu@ihcams.ac.cn;

  联系人:陈波宇

  联系电话:+86-022-23909037

中国医学科学院血液病医院  

(中国医学科学院血液学研究所)

人力资源处             

2020年2月17日     

Calls for Global Talents

Institute of Hematology and Blood Diseases Hospital, Tianjin, China

Institute of Hematology and Blood Diseases Hospital (IH), Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS/PUMC), founded in 1957, is the largest national research-oriented medical institution for blood diseases in China, which integrates patient care, medical research, specialty teaching and relevant research product commercialization. It is the sole top-graded hematology specialty hospital directly under the National Health Commission of the People’s Republic of China. It houses the State Key Laboratory of Experimental Hematology and the National Clinical Medical Research Center for Blood Diseases, focusing on basic and applied research of hematological diseases, regenerative medicine and other related fields. It is the founding and leading hospital for the China Alliance for Blood Diseases, whose network covers 140 major hospitals in 32 provinces of China. IH currently opens 766 beds with more than 10 clinical treatment centers divided by specific disease. In addition to routine clinical services with more than 200,000 annual visits and more than 30,000 hospitalized patients each year, IH has led the most multi-center trials on new diagnostic methods and drugs/therapies of hematological diseases, implemented the standardization of the clinical protocols and conducted professional trainings for hematology practitioners in China. It has won the first place in the hematology specialty ranking for ten consecutive years since 2010 and ranked the first in hematology by the Scientific and Technological Evaluation Metrics (STEM) for Chinese hospitals for six consecutive years since 2014. It should be noted that international collaboration has always been the development strategy and strength of IH as exemplified by the newly awarded title “National Belt and Road Initiative Joint Laboratory in Population Medical Science”.

The CAMS/PUMC recently implemented an internationally-comparable tenure and tenure-track system for faculty evaluation, which IH has also adopted for new faculty recruitment. In addition, IH established a "personalized" recruitment package, providing sufficient start-up funds and more importantly offering unique yet attractive research platforms for the fast development of academic career.  Applicants with MD, PhD or equivalent degree at early or middle career stage in relevant fields should send their applications to

Ms. Boyu Chen (chenboyu@ihcams.ac.cn); Tel: +86-22-23909037

Department of Human Resources, Institute of Hematology and Blood Diseases Hospital

288 Nanjing Road, Tianjin 300020, China;

Open Positions for 2020

NO.

Title

Specialty

Special Requirements

1

Director of

Hemapathology Center

Hematology, Pathology or Related Fields

  1. Strong background in clinical pathology, hematology or other relevant fields from globally leading universities or research institutes.
  2. Strong communication, management and organizational skills.
  3. Preferred with the following conditions:
  1. High impact research publications in high-end academic journals.
  2. Leadership positions in national or international academic societies in related fields.
  3. Board-certified in pathology or medicine (hematology) in developed countries.

2

Director of Information and Resources Center

Bioinformatics or Medical Big Data

  1. Strong background in biostatistics, epidemiology, bioinformatics or medical big data from globally leading universities, research institutes or industry.
  2. Strong communication, management and organizational skills.
  3. Experienced in EMR database or regional database research or medical complex big data model research and applications.

3

Principal Investigator of the State key Laboratory of Experimental Hematology and the National Clinical Research Center for Blood Diseases

Epidemiology or/and Molecular Epidemiology

  1. Equivalent to assistant professor, staff scientist or above in globally leading universities or research institutes.
  2. High impact research publications in high-end academic journals.
  3. Preferred with the following conditions:
  1. Team leader for research in relevant fields.
  2. Independent research grant or fellowship in relevant fields.
  3. Prestigious academic awards in China or abroad.

4

Bioinformatics or/and Big Data

5

Clinical Trials or/and Biostatistics

6

Gene Editing and Gene Therapy

7

Experimental Hematology or/and Stem Cell Biology

                                                                                                                                                          

 

   
网站导航 | 联系我们 | 使用帮助 | 网站声明


主办:中国医学科学院血液学研究所血液病医院  技术支持:北方网
  备案序号:津ICP备05001070号
建议使用IE6.0以上浏览器,分辨率1024*768